🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to learn if adding bevacizumab to standar...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2009-05
Trial ID
NCT00887536
Treatments Being Tested
The purpose of this study is to compare the association between image and c...
Status
Completed
Location
Hospital Obispo Polanco
Start Date
2009-10
Trial ID
NCT01338753
Treatments Being Tested
The purpose of this study is to evaluate a novel neoadjuvant regimen for in...
Status
Unknown
Location
Hospital Auxilio Mutuo Cancer Center
Start Date
2011-03
Trial ID
NCT01641406
The main purpose is to learn if adding bevacizumab to standard chemotherapy...
Status
Completed
Location
Clearview Cancer Institute- Huntsville
Start Date
2007-05
Trial ID
NCT00464646
Treatments Being Tested
Bevacizumab is an angiogenesis inhibitor which means it works to stop blood...
Status
Completed
Location
NSABP Foundation, Inc.
Start Date
2006-08
Trial ID
NCT00365417
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested